Illan-Gala, I, Montal, V, Borrego-Ecija, S, Mandelli, ML, Falgas, N, Welch, AE, Pegueroles, J, Santos-Santos, M, Bejanin, A, Alcolea, D, Dols-Icardo, O, Belbin, O, Sanchez-Saudinos, MB, Bargallo, N, Gonzalez-Ortiz, S, Llado, A, Blesa, R, Dickerson, BC, Rosen, HJ, Miller, BL, Lleo, A, Gorno-Tempini, ML, Sanchez-Valle, R, Fortea, J. Cortical microstructure in primary progressive aphasia: a multicenter study. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-00974-0. PMID:35139897. IF:9.000(Q1/1D).

Cebrian-Cuenca, AM, Mata-Cases, M, Franch-Nadal, J, Mauricio, D, Orozco-Beltran, D, Consuegra-Sanchez, L. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population. European Journal of Preventive Cardiology. 2022; 28(18)DOI:10.1093/eurjpc/zwaa073. PMID:33733654. IF:8.300(Q1/2D).

van Poppel, MNM, Corcoy, R, Hill, D, Simmons, D, Mendizabal, L, Zulueta, M, Simon, L, Desoye, G, Perez, JMA, Kautzky-Willer, A, Harreiter, J, Damm, P, Mathiesen, E, Jensen, DM, Andersen, LLT, Dunne, F, Lapolla, A, Dalfra, MG, Bertolotto, A, van Poppel, M, Jelsma, JGM, Snoek, FJ, Galjaard, S, Wender-Ozegowska, E, Zawiejska, A, Devlieger, R, DALI Core Investigator Grp. Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial. AMERICAN JOURNAL OF CLINICAL NUTRITION. 2022; 115(2)DOI:10.1093/ajcn/nqab347. PMID:34669935. IF:7.100(Q1/2D).

Hughes, DA, Aguiar, P, Lidove, O, Nicholls, K, Nowak, A, Thomas, M, Torra, R, Vujkovac, B, West, ML, Feriozzi, S. Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?. Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02181-4. PMID:35135579. IF:3.700(Q2/4D).